Skip to main content
Journal ArticleOPEN ACCESS

Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy

  • Butler J
  • Epstein S
  • Greene S
  • et al.
Circulation Research (2017) 120(2) 332-340
DOI: 10.1161/circresaha.116.309717
N/ACitations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Rationale:Potential benefits of mesenchymal stem cell (MSC) therapy in heart failure may be related to paracrine properties and systemic effects, including anti-inflammatory activities. If this hyp...

Cite

CITATION STYLE

APA

Butler, J., Epstein, S. E., Greene, S. J., Quyyumi, A. A., Sikora, S., Kim, R. J., … Gheorghiade, M. (2017). Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy. Circulation Research, 120(2), 332–340. https://doi.org/10.1161/circresaha.116.309717

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free